ArticleScience translational medicine2016

Development of a prosaposin-derived therapeutic cyclic peptide that targets ovarian cancer via the tumor microenvironment.

Suming Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.